Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

Finasteride negatively affects fish reproduction and gonadal development.

Apoptosis may contribute to hair loss in androgenetic alopecia.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Exposure to certain chemicals in food and containers may increase the risk of early breast development in young girls.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

An integrative approach combining medical, nutritional, and lifestyle changes effectively manages female pattern hair loss.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

The herbal hair oil effectively nourishes hair and helps with dandruff, hair loss, and split ends without causing skin irritation.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

Insulin resistance and nesfatin-1 are linked to acne severity.

Using tiny fat particles to deliver arginine to hair follicles could be a new way to treat hair loss.

People with vitiligo tend to have lower vitamin D levels.

Finasteride for hair loss has minimal impact on sexual function.